CVRdatabase
Menu

Ferring Pharmaceuticals A/S

Public limited companyCVR 16313440KastrupActive

Ferring Pharmaceuticals A/S is a public limited company, based in Kastrup, active in research and experimental development on natural sciences and engineering, founded in 1992. Net profit fell 36% from 2024 to 2025, ending at DKK 49m. Measured by gross profit, it ranks no. 7 of 421 companies in the industry in the database. With 508 employees, the company is about 102 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 1.7bn+2.4% vs. 2024
Net profitDKK 49m−36.3% vs. 2024
EquityDKK 315.2m+18.4% vs. 2024
Employees508latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 2% (2024 → 2025), to DKK 824.4m.
  • Revenue rose 2% (2024 → 2025), to DKK 1.7bn.
  • Net profit fell 36% (2024 → 2025), to DKK 49m.
  • Equity rose 18% (2024 → 2025), to DKK 315.2m.

Employees

  • 136 fewer employees than a year earlier: 508 (08/2026) against 644 (08/2025).

Management and owners, last 24 months

  • New in management: Jesper Thomsen (director, 15/09/2025), Ingbritt Tolstrup Birk (director, 01/02/2026) and Jesper Thomsen (board member, 15/09/2025) (+1).
  • Stepped down: Klaus Grønbæk Jakobsen (director, 21/07/2025), Lene Melchiorsen (director, 01/02/2026) and Anette Hedegaard Østergaard (director, 21/07/2025) (+3).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250mDKK 300m202020212022202320242025
EquityNet profit
Financial figures for Ferring Pharmaceuticals A/S
202020212022202320242025Change
Revenue1,051,4681,005,4681,261,4321,457,5091,690,2941,730,413+2.4%
Gross profit1,051,4681,005,468645,934707,843811,057824,399+1.6%
Operating profit (EBIT)56,54754,03566,54088,956103,162120,592+16.9%
Profit before tax52,75152,05963,94586,23598,972113,891+15.1%
Net profit40,92840,17452,37767,11076,89049,005−36.3%
Total assets381,839472,880485,671586,405554,485671,064+21%
Equity79,44469,618121,995189,325266,214315,220+18.4%
Liabilities294,410394,084355,819390,813282,477314,453+11.3%
Cash and cash equivalents297313091,2503490−100%
Average number of employees497487559578601577−4%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 200mDKK 400mDKK 600mDKK 800mDKK 1bn202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Ferring Pharmaceuticals A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202406/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202329/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202209/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202125/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202022/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
010020030040050060070080009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 824.4mNo. 7 of 421
Better than 99% of the companies in the industry
EquityDKK 315.2mNo. 11 of 431
Better than 98% of the companies in the industry
Number of employees508No. 4 of 431
Better than 99% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 500–999 employees207 companies in the comparison
No. 34of 189
Better than 82%
No. 93of 207
Better than 55%
Companies that are at least 30 years old10,276 companies in the comparison
No. 109of 10,152
Better than 99%
No. 542of 10,275
Better than 95%
All companies of type A/S18,025 companies in the comparison
No. 174of 17,786
Better than 99%
No. 1,013of 18,024
Better than 94%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Ferring Pharmaceuticals A/SDKK 824.4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Ferring Pharmaceuticals A/SDKK 49m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Ferring Pharmaceuticals A/SDKK 315.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Ferring Pharmaceuticals A/S508
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Ferring B.V.100%
Ferring Pharmaceuticals A/S

Management

7 active registrations

Executive management

Executive management at Ferring Pharmaceuticals A/S
NameRoleAppointed
Kim Fonager JensenDirector10/12/2021
Jan PeutzfeldtCEO01/02/2024
Jesper ThomsenDirector15/09/2025
Ingbritt Tolstrup BirkDirector01/02/2026

Board of directors

Board of directors at Ferring Pharmaceuticals A/S
NameRoleAppointed
Dag Frederik Arfst PaulsenBoard member24/08/2005
Marianne KockChair of the board01/02/2024
Jean-Frederic PaulsenBoard member01/03/2024
Founders
Medimex ApS, ApS Kbil 9 Nr. 1008, VX 20.181 ApS
Former management (30)
Former management at Ferring Pharmaceuticals A/S
NameRoleAppointedResigned
Mats LundwallDirector13/03/198007/10/1998
Hans Christian GalstBoard member01/08/199221/09/1993
Ulf Svejgaard PoulsenChair of the board01/08/199221/09/1993
Per Emil Hasselbalch StakemannBoard member01/08/199221/09/1993
Per Emil Hasselbalch StakemannDirector01/08/199221/09/1993
Eva Wolf PaulsenBoard member01/08/199212/02/1998
Eva Wolf PaulsenDirector01/08/199207/12/1994
Åke Stefan WarinDirector01/08/199213/03/1998
Mats LundwallBoard member01/08/199207/10/1998
Christiaan Paul ThomasBoard member12/02/199830/11/2001
Christiaan Paul ThomasDirector07/10/199830/11/2001
Jeffrey David HobbsBoard member07/10/199815/08/2005
Jean Louis JunienBoard member07/10/199820/12/2000
Pascal Rene Olivier DanglasBoard member14/06/200414/03/2017
Ole Kjerulf-JensenChair of the board24/08/200510/12/2021
Ole Kjerulf-JensenDirector24/08/200524/08/2005
Pascal Rene Olivier DanglasDirector24/08/200501/02/2015
Marianne KockDirector18/05/200605/06/2006
Marianne KockCEO06/06/200601/02/2024
Per Gunnar FalkBoard member14/03/201709/12/2021
Bolette WildtDirector10/12/202101/08/2023
Marianne KockBoard member10/12/202131/01/2024
Per Gunnar FalkChair of the board10/12/202101/02/2024
Armin MetzgerBoard member11/08/202301/03/2024
Klaus Grønbæk JakobsenDirector22/12/202321/07/2025
Lene MelchiorsenDirector22/12/202301/02/2026
Anette Hedegaard ØstergaardDirector01/03/202421/07/2025
Pierre Yves BerclazBoard member01/03/202423/03/2026
Jesper ThomsenBoard member15/09/202515/09/2025
Tamara VukmirovicDirector24/10/202503/09/2026

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør eller af to direktører i forening

Address and production units

1 active production units

Amager Strandvej 405
2770 Kastrup

Tårnby Municipality · Postcode 2770

Other companies at the address (1)

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
FERRING PHARMACEUTICALS A/SAmager Strandvej 405, 2770 Kastrup5081001077436

Purpose

Selskabets formål er forskning og udvikling af farmaceutiske produkter for selskaber i Ferring koncernen.

The purpose is quoted from the register in Danish.

Changes year by year

85 registered events
20265 changesmanagement 4 · accounts 1
  • Tamara Vukmirovic stepped down as director
  • Annual report for 2025 published
  • Pierre Yves Berclaz stepped down as board member
  • Ingbritt Tolstrup Birk appointed director
  • Lene Melchiorsen stepped down as director
20258 changesmanagement 6 · accounts 1 · industry 1
  • Tamara Vukmirovic appointed director
  • Jesper Thomsen appointed board member
  • Jesper Thomsen stepped down as board member
  • Jesper Thomsen appointed director
  • Anette Hedegaard Østergaard stepped down as director
  • Klaus Grønbæk Jakobsen stepped down as director
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202410 changesaccounts 1 · management 9
  • Annual report for 2023 published
  • Pierre Yves Berclaz appointed board member
  • Anette Hedegaard Østergaard appointed director
  • Jean-Frederic Paulsen appointed board member
  • Armin Metzger stepped down as board member
  • Jan Peutzfeldt appointed ceo
  • Marianne Kock appointed chair of the board
  • Per Gunnar Falk stepped down as chair of the board
  • Marianne Kock stepped down as ceo
  • Marianne Kock stepped down as board member
20235 changesmanagement 4 · accounts 1
  • Lene Melchiorsen appointed director
  • Klaus Grønbæk Jakobsen appointed director
  • Armin Metzger appointed board member
  • Bolette Wildt stepped down as director
  • Annual report for 2022 published
20223 changesaddress 2 · accounts 1
  • Moved to Amager Strandvej 405, 2770 Kastrup
  • Annual report for 2021 published
  • Moved to Amager Strandvej 405, 2770 Kastrup
20217 changesmanagement 6 · accounts 1
  • Bolette Wildt appointed director
  • Kim Fonager Jensen appointed director
  • Per Gunnar Falk appointed chair of the board
  • Marianne Kock appointed board member
  • Ole Kjerulf-Jensen stepped down as chair of the board
  • Per Gunnar Falk stepped down as board member
  • Annual report for 2020 published
20202 changesaddress 2
  • Moved to Kay Fiskers Plads 11, 2300 København S
  • Moved to Kay Fiskers Plads 11, 2300 København S
20172 changesmanagement 2
  • Per Gunnar Falk appointed board member
  • Pascal Rene Olivier Danglas stepped down as board member
20151 changemanagement 1
  • Pascal Rene Olivier Danglas stepped down as director
20081 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20063 changesmanagement 3
  • Marianne Kock appointed ceo
  • Marianne Kock stepped down as director
  • Marianne Kock appointed director
20056 changesmanagement 6
  • Pascal Rene Olivier Danglas appointed director
  • Dag Frederik Arfst Paulsen appointed board member
  • Ole Kjerulf-Jensen appointed director
  • Ole Kjerulf-Jensen stepped down as director
  • Ole Kjerulf-Jensen appointed chair of the board
  • Jeffrey David Hobbs stepped down as board member
20041 changemanagement 1
  • Pascal Rene Olivier Danglas appointed board member
20022 changesaddress 1 · industry 1
  • Moved to Kay Fiskers Plads 11, 2300 København S
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
20012 changesmanagement 2
  • Christiaan Paul Thomas stepped down as director
  • Christiaan Paul Thomas stepped down as board member
20001 changemanagement 1
  • Jean Louis Junien stepped down as board member
19991 changename 1
  • Name changed from FERRING NORDIC PHARMACEUTICALS A/S to FERRING PHARMACEUTICALS A/S
19988 changesmanagement 8
  • Jean Louis Junien appointed board member
  • Jeffrey David Hobbs appointed board member
  • Christiaan Paul Thomas appointed director
  • Mats Lundwall stepped down as board member
  • Mats Lundwall stepped down as director
  • Åke Stefan Warin stepped down as director
  • Christiaan Paul Thomas appointed board member
  • Eva Wolf Paulsen stepped down as board member
19971 changeownership 1
  • Ferring B.V. registered as owner (100%)
19941 changemanagement 1
  • Eva Wolf Paulsen stepped down as director
19935 changesname 1 · management 4
  • Name changed from A/S PSE 38 NR. 1587 to FERRING NORDIC PHARMACEUTICALS A/S
  • Hans Christian Galst stepped down as board member
  • Per Emil Hasselbalch Stakemann stepped down as director
  • Per Emil Hasselbalch Stakemann stepped down as board member
  • Ulf Svejgaard Poulsen stepped down as chair of the board
19929 changesfounded 1 · management 8
  • Registered as A/S PSE 38 NR. 1587
  • Hans Christian Galst appointed board member
  • Mats Lundwall appointed board member
  • Åke Stefan Warin appointed director
  • Eva Wolf Paulsen appointed director
  • Eva Wolf Paulsen appointed board member
  • Per Emil Hasselbalch Stakemann appointed director
  • Per Emil Hasselbalch Stakemann appointed board member
  • Ulf Svejgaard Poulsen appointed chair of the board
19801 changemanagement 1
  • Mats Lundwall appointed director

Related companies

Same industry in Tårnby

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026.

View in CVRReport a correction